Humacyte, Inc.

Ownership Transactions Reported by 24 Insiders

Symbol
HUMA, HUMAW on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
Location
2525 East North Carolina Highway 54, Durham, NC

Insiders trading volume in the past year

Humacyte, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Brady W. Dougan Director $16M -$27M -62.8% Nov 18, 2024
Laura E. Niklason President, CEO and Director, Director $16M -$27M -62.8% Nov 18, 2024
Ayabudge LLC 10%+ Owner $9.75M Aug 17, 2023
Gordon M. Binder Director $1.41M +$668K +89.5% May 15, 2024
Max N. Wallace Director $406K +$50K +14.1% Jun 13, 2024
Kathleen Sebelius Director $222K -$28K -11.2% Sep 10, 2024
Dale A. Sander CFO and Chief Corp. Deve. Off. $151K -$263K -63.5% Aug 27, 2024
Michael T. Constantino Director $77.7K +$19.5K +33.5% Aug 15, 2024
William Edward Tente Chief Regulatory Officer $62.5K Aug 26, 2021
William John Scheessele Chief Commercial Officer $18.5K Dec 8, 2023
Charles Bruce Green Director $9.82K Sep 13, 2024
Jeffrey Harold Lawson Chief Surgical Officer, Director $9.37K Aug 26, 2021
Heather Ledbetter Prichard Chief Operating Officer $0 -$1.56M -100% May 30, 2024
Yang Cao Chief Regulatory Officer Dec 8, 2023
Keith Anthony Jones Director Jun 13, 2024
Susan Windham-Bannister Director Jun 13, 2024
Todd Pope Director Jun 13, 2024
Emery N. Brown Director Jun 13, 2024
Kiernan Thomas DeAngelis Chief Medical Officer Aug 26, 2021
Fresenius Medical Care Holdings Inc /Ny/ 10%+ Owner Aug 26, 2021
Rajiv Shukla Director Jun 15, 2023
Shamik J. Parikh Chief Medical Officer Dec 8, 2023
Diane Seimetz Director Jun 13, 2024
John Philip Bamforth Director Jun 13, 2024

Recent Insider Transactions by Companies or Individuals for Humacyte, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.